✦ LIBER ✦

Re: Cost-Effectiveness Analysis of Degarelix for Advanced Hormone-Dependent Prostate Cancer

✍ Scribed by Penson, David F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of degarelix

✍ Lanting Lu; Jaime Peters; Chris Roome; Ken Stein 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

PCN100 A Cost–Utility Analysis of Degare

✍ Fisher, D.; Brereton, N.J.; Kildegaard nielsen, S.; Tate, E. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN70 The Cost Effectiveness of Degareli

✍ D. Lee; D. Gladwell; S.K. Nielsen; E. Tate; N.J. Brereton 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Re: Racial Variation in the Cost-Effecti

✍ Penson, David F. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 92 KB

PCN122 COST-EFFECTIVENESS ANALYSIS OF HO

✍ S Iannazzo; L Pradelli; M Perachino 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

CA3: ESTIMATING SURVIVAL GAIN FOR COST-E

✍ N Neymark; I Adriaenssen; S Caleo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB